Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Seth J. Zost(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Jinhui Dong(Vanderbilt University Medical Center), Natalie J. Thornburg(Oak Ridge Associated Universities), Sandhya Bangaru(Government Medical College), Pavlo Gilchuk(AstraZeneca (Japan)), Nurgun Kose(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Hannah L. Turner(Scripps Research Institute), Ryan P. Irving(Vanderbilt University Medical Center), Naveenchandra Suryadevara(Vanderbilt University), Jessica A. Finn, Robin Bombardi(Vanderbilt University Medical Center), Cinque Soto(National Institutes of Health), Andrew B. Ward(Scripps Research Institute), Jonna B. Westover(Utah State University), Sheng Li(University of California San Diego), Iuliia M. Gilchuk(Vanderbilt University Medical Center)
Cited by 6
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
|Science Translational Medicine|2020|1.2k
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k